Annexon, Inc. - common stock (ANNX)
4.8000
-0.1100 (-2.24%)
NASDAQ · Last Trade: Dec 16th, 10:40 PM EST
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · November 19, 2025
Via Benzinga · November 19, 2025
Via Benzinga · November 14, 2025

ANNX stock results show that Annexon met analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 12, 2024

ANNX stock results show that Annexon beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 13, 2024
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · July 10, 2025
Via Benzinga · May 14, 2025
Via Benzinga · May 13, 2025
Annexon's tanruprubart showed significant and sustained functional gains in Guillain-Barré patients, meeting key Phase 3 trial endpoints.
Via Benzinga · April 9, 2025
Via Benzinga · March 17, 2025

Via Benzinga · July 12, 2024

While blue-chip stocks are great, it's also a good idea to invest in top stocks under $10 to help improve your portfolio's diversification.
Via InvestorPlace · June 24, 2024

Via Benzinga · June 5, 2024

Via Benzinga · June 5, 2024

Via Benzinga · June 4, 2024

Via Benzinga · June 4, 2024

Annexon reports positive Phase 3 trial results for ANX005 in Guillain-Barré syndrome, showing significant improvements in disability, muscle strength, and ventilation duration.
Via Benzinga · June 4, 2024

Via Benzinga · June 4, 2024

Via Benzinga · June 4, 2024

Via Benzinga · June 4, 2024

It's time to start Tuesday with a breakdown of the biggest pre-market stock movers traders will want to know about this morning!
Via InvestorPlace · June 4, 2024


